The purpose of the study was to assess the impact of dutasteride plus tamsulosin combination therapy , compared with dutasteride or tamsulosin monotherapy , on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia ( LUTS/BPH ) using data from the 4-year CombAT study .